TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
BWT Pharma & Biotech AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
325,756
|
222,081
|
147,667 |
Financial expenses |
5
|
30
|
31 |
Earnings before taxes |
52,301
|
32,238
|
17,739 |
EBITDA |
51,202
|
32,467
|
18,085 |
Total assets |
238,857
|
135,346
|
103,976 |
Current assets |
237,838
|
134,345
|
102,765 |
Current liabilities |
173,871
|
92,928
|
61,641 |
Equity capital |
63,666
|
35,562
|
25,631 |
- share capital |
336
|
334
|
364 |
Employees (average) |
48
|
42
|
37 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
26.7%
|
26.3%
|
24.7% |
Turnover per employee |
6,787
|
5,288
|
3,991 |
Profit as a percentage of turnover |
16.1%
|
14.5%
|
12.0% |
Return on assets (ROA) |
21.9%
|
23.8%
|
17.1% |
Current ratio |
136.8%
|
144.6%
|
166.7% |
Return on equity (ROE) |
82.1%
|
90.7%
|
69.2% |
Change turnover |
102,532
|
86,374
|
-507 |
Change turnover % |
46%
|
64%
|
0% |
Chg. No. of employees |
6
|
5
|
9 |
Chg. No. of employees % |
14%
![]() |
14%
|
32% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.